InSyBio

Narragansett, United States

InSyBio is a disruptor to Precision Medicine & Nutrition through effective personalization tests empowered with machine-learning.

$100K raised

Jul 2023

Series A

Top Investors

Loyal VC

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has InSyBio raised?

InSyBio has raised $100K in total funding. The most recent round was Series A. The last funding was announced in July 2023.

Who are InSyBio's investors?

InSyBio's investors include Loyal VC.

Where is InSyBio headquartered?

InSyBio is headquartered in Narragansett, United States.

What does InSyBio do?

InSyBio is a disruptor to Precision Medicine & Nutrition through effective personalization tests empowered with machine-learning.

What stage is InSyBio at?

InSyBio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 1, 2023.

MLA

"InSyBio — Funding & Investors." VCBacked, July 1, 2023, https://www.vcbacked.co/company/insybio. Accessed June 17, 2026.

APA

VCBacked. (2023). InSyBio — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/insybio

Wikipedia (cite web)

{{cite web |title=InSyBio — Funding & Investors |url=https://www.vcbacked.co/company/insybio |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 1, 2023.